Effect of the enamel matrix derivative Emdogain on the growth of periodontal pathogens in vitro
- PMID: 11846851
- DOI: 10.1034/j.1600-051x.2002.290110.x
Effect of the enamel matrix derivative Emdogain on the growth of periodontal pathogens in vitro
Abstract
Objectives: The aim of this study was to evaluate the effect of Emdogain (EMD), used for periodontal regeneration, on the growth of periodontal pathogens like Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis and Prevotella intermedia. For comparison, we studied the effect of EMD on several microbes associated with other oral diseases as well as its effect on non-pathogenic oral inhabitants.
Methods: Freshly prepared EMD or its vehicle propylene glycol alginate (PGA) alone were added to calibrated suspensions of microbes. As a control, imitating the post-surgical subgingival situation after flap closure, a serum/NaCl-solution mixture was used. Aliquots for growth assays were taken at scheduled times for calculation of colony-forming units and cell densities over an observation period of 24 h. Additionally, EMD was spotted onto selected, newly seeded microbes growing on agar plates to see if growth inhibition zones could be produced.
Results: The study revealed a marked inhibitory effect of EMD on the growth of the gram-negative periodontal pathogens. A. actinomycetemcomitans showed a significant decrease (p=0.012) in viable counts after 24 h when EMD was added at baseline. P. gingivalis and P. intermedia also showed a marked growth reduction in the presence of EMD and in these cultures no viable microbes could be detected anymore after 24 h. In contrast, no significant growth inhibition was observed in gram-positive bacteria.
Conclusions: The results suggest that EMD has a positive effect on the composition of bacterial species in the post-surgical periodontal wound, by selectively restricting growth of periopathogens that could hamper the wound healing and reduce the outcome of regenerative procedures.
Similar articles
-
Effects of enamel matrix derivative on Porphyromonas gingivalis.J Periodontol. 2003 Aug;74(8):1191-5. doi: 10.1902/jop.2003.74.8.1191. J Periodontol. 2003. PMID: 14514233
-
Moderate effect of enamel matrix derivative (Emdogain Gel) on Porphyromonas gingivalis growth in vitro.Arch Oral Biol. 2006 Mar;51(3):171-6. doi: 10.1016/j.archoralbio.2005.07.005. Epub 2005 Aug 31. Arch Oral Biol. 2006. PMID: 16137640
-
Antimicrobial activity of silver nitrate against periodontal pathogens.J Periodontal Res. 2001 Apr;36(2):108-13. doi: 10.1034/j.1600-0765.2001.360207.x. J Periodontal Res. 2001. PMID: 11327077
-
Effect of an enamel matrix protein derivative (Emdogain) on ex vivo dental plaque vitality.J Clin Periodontol. 2001 Nov;28(11):1074-8. doi: 10.1111/j.1600-051X.2001.281113.x. J Clin Periodontol. 2001. PMID: 11686830
-
The evaluation of enamel matrix derivative on subgingival microbial environment in non-surgical periodontal therapy.Ann Agric Environ Med. 2013;20(3):431-5. Ann Agric Environ Med. 2013. PMID: 24069844 Clinical Trial.
Cited by
-
Enamel matrix protein derivatives: role in periodontal regeneration.Clin Cosmet Investig Dent. 2011 Dec 1;3:79-92. doi: 10.2147/CCIDEN.S25347. Print 2011. Clin Cosmet Investig Dent. 2011. PMID: 23674918 Free PMC article.
-
Cellular effects of enamel matrix derivative are associated with different molecular weight fractions following separation by size-exclusion chromatography.J Periodontol. 2009 Apr;80(4):648-56. doi: 10.1902/jop.2009.070420. J Periodontol. 2009. PMID: 19335085 Free PMC article.
-
Microbiological and clinical effects of enamel matrix derivative and sustained-release micro-spherical minocycline application as an adjunct to non-surgical therapy in peri-implant mucosal inflammation.J Korean Assoc Oral Maxillofac Surg. 2015 Aug;41(4):181-9. doi: 10.5125/jkaoms.2015.41.4.181. Epub 2015 Aug 21. J Korean Assoc Oral Maxillofac Surg. 2015. PMID: 26339576 Free PMC article.
-
Effects of enamel matrix derivative in nonsurgical periodontal therapy on pro-inflammatory profiles, microbial environment and clinical outcome: a randomized clinical trial.Clin Oral Investig. 2023 Nov;27(11):6493-6502. doi: 10.1007/s00784-023-05254-1. Epub 2023 Oct 16. Clin Oral Investig. 2023. PMID: 37843637 Free PMC article. Clinical Trial.
-
Injectable Platelet-Rich Fibrin and Advanced Platelet-Rich Fibrin Demonstrate Enhanced Anti-Biofilm Effect Compared to Enamel Matrix Derivatives on Decontaminated Titanium Surfaces.Dent J (Basel). 2024 Jun 6;12(6):175. doi: 10.3390/dj12060175. Dent J (Basel). 2024. PMID: 38920876 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials